Immunovant Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with autoimmune diseases. With a strong pipeline and cutting-edge research, Immunovant aims to address unmet medical needs and improve the lives of those suffering from debilitating conditions.
Notification